Hints and tips:
Showing results for FOUGERA PHARMCEUTICALS, INC.
...Fougera has 45 products and it operates PharmaDerm, a speciality drug company with 17 brands. Novartis was advised by Jefferies and Fougera was advised by Credit Suisse and Rothschild....
...For instance, Amgen late last month bought MN of Turkey for $700m, and Novartis this week paid $1.5bn for Fougera, a generic dermatology products group....
...Examples include GSK, Johnson & Johnson, Sanofi and Novartis, which diversified further this week with the $1.5bn purchase of Fougera, a dermatology generics company....
...Novartis agreed on Wednesday to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525bn in cash, reports NYT DealBook....
...Watson Pharmceuticals is close to an almost-$7bn bid for Actavis....
...Sawai Pharmaceutical, Japan’s biggest generic drug maker, soared 13 per cent to Y3,740 while Towa Pharmceutical gained 8 per cent to Y4,690. Strong results helped boost several household names....
International Edition